Both individual patient and health considerations are extremely important when addressing a health issue of the magnitude of hypertension, which, as noted in the previous column, was recently and authoritatively designated as the greatest threat to the global burden of disease. R. J. Turner and Philip Galtry at Quintiles explain that therapeutically beneficial interactions between individual patients and their physicians are the cornerstone of the practice of both behavioural medicine and  biopharmaceutical medicine.
http://jforcs.com/jcs/wp-content/uploads/2013/10/Cardiovascular-Therapeutics…pdf